Group One Trading, L.P. Iovance Biotherapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,282,968 shares of IOVA stock, worth $10.4 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

1,282,968

Previous 731,607 75.36%

Holding current value

$10.4 Million

Previous $5.87 Million 105.33%

% of portfolio

0.5%

Previous 0.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $4.01 Million - $6.56 Million	551,361 Added 75.36%	1,282,968 $12 Million
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $1.89 Million - $3.46 Million	243,569 Added 49.91%	731,607 $5.87 Million
Q1 2024 May 10, 2024	SELL	$7.59 - $17.47 $669,923 - $1.54 Million	-88,264 Reduced 15.32%	488,038 $7.23 Million
Q4 2023 Feb 14, 2024	SELL	$3.3 - $8.89 $163,016 - $439,157	-49,399 Reduced 7.89%	576,302 $4.69 Million
Q3 2023 Nov 09, 2023	BUY	$4.44 - $8.79 $2.33 Million - $4.6 Million	523,723 Added 513.56%	625,701 $2.85 Million
Q2 2023 Aug 09, 2023	BUY	$5.36 - $9.06 $223,763 - $378,227	41,747 Added 69.31%	101,978 $717,000
Q1 2023 May 12, 2023	SELL	$5.53 - $8.22 $389,555 - $579,049	-70,444 Reduced 53.91%	60,231 $368,000
Q4 2022 Feb 09, 2023	BUY	$5.62 - $10.0 $366,069 - $651,370	65,137 Added 99.39%	130,675 $835,000
Q3 2022 Nov 09, 2022	SELL	$9.53 - $13.11 $523,997 - $720,840	-54,984 Reduced 45.62%	65,538 $628,000
Q2 2022 Aug 11, 2022	BUY	$6.38 - $18.33 $762,097 - $2.19 Million	119,451 Added 11153.22%	120,522 $1.33 Million
Q1 2022 May 12, 2022	SELL	$12.38 - $19.1 $394,476 - $608,602	-31,864 Reduced 96.75%	1,071 $18,000
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $2.1 Million - $3.5 Million	-126,809 Reduced 79.38%	32,935 $629,000
Q3 2021 Nov 12, 2021	BUY	$20.35 - $26.63 $3.25 Million - $4.25 Million	159,744 New	159,744 $3.94 Million
Q2 2021 Aug 10, 2021	SELL	$16.33 - $33.07 $229,191 - $464,137	-14,035 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$28.67 - $52.59 $402,383 - $738,100	14,035 New	14,035 $444,000
Q4 2020 Feb 10, 2021	SELL	$28.04 - $50.26 $1.29 Million - $2.32 Million	-46,117 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $1.28 Million - $1.67 Million	46,117 New	46,117 $1.52 Million
Q3 2019 Nov 12, 2019	SELL	$17.99 - $26.0 $245,275 - $354,484	-13,634 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$9.78 - $24.52 $133,340 - $334,305	13,634 New	13,634 $334,000
Q1 2019 May 13, 2019	SELL	$8.41 - $11.26 $129,539 - $173,437	-15,403 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$7.51 - $11.93 $115,676 - $183,757	15,403 New	15,403 $136,000
Q3 2018 Nov 08, 2018	SELL	$11.25 - $17.7 $79,256 - $124,696	-7,045 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $87,710 - $119,412	7,045 New	7,045 $90,000
Q4 2017 Feb 09, 2018	SELL	$6.65 - $9.25 $811 - $1,128	-122 Closed	0 $0
Q3 2017 Nov 15, 2017	SELL	$4.45 - $8.55 $18,156 - $34,884	-4,080 Reduced 97.1%	122 $1,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,202	4,202 $31,000

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Iovance Biotherapeutics, Inc. Transaction History